Dexamethasone suppression test in patients with Parkinson's disease

The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into s...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 5; no. 1; p. 23
Main Authors Kostić, V S, Covicković-Sternić, N, Beslać-Bumbasirević, L, Ocić, G, Pavlović, D, Nikolić, M
Format Journal Article
LanguageEnglish
Published United States 1990
Subjects
Depression - diagnosis
Depression - etiology
Dexamethasone
Humans
Middle Aged
Parkinson Disease - complications
Online AccessGet more information

Cover

More Information
Summary:The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).
ISSN:0885-3185
DOI:10.1002/mds.870050106